DreamWell

DreamWell — Sleep-State Neuromodulation Research Solution

Stabilized Liquid Nasal Delivery System

DreamWell is a multi-component research formulation designed for controlled laboratory investigation of inhibitory neural signaling and sleep-state transition dynamics.

This stabilized liquid system combines well-characterized compounds studied for their influence on central inhibitory tone, circadian rhythm regulation, and synaptic excitability within experimental models.

Formulation Components:

• DSIP (Delta Sleep-Inducing Peptide) — studied in relation to sleep-cycle modulation and neuroendocrine signaling pathways
• Pharma-Grade GABA — a primary inhibitory neurotransmitter researched for its role in reducing neuronal excitability and neural downregulation
• Melatonin — a circadian-phase signaling molecule widely examined for rhythm synchronization and biological timing control

These components are integrated into a uniform dispersion matrix designed to support consistent volumetric delivery and reproducibility across laboratory settings.

Research Applications

DreamWell is utilized in experimental models to explore:

• Inhibitory neurotransmission balance
• Circadian phase-shift mechanisms
• Sleep-state onset modeling
• Neurochemical downregulation pathways
• Synaptic quieting and signaling suppression dynamics

This formulation enables structured investigation into how coordinated inhibitory signaling influences transitions between wakeful and rest-associated neural states.

Research Use Only — Not for Human Consumption